Search - tctmd.com

Displaying 61 - 80 of 166

Sort: Relevancy | Date

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

Presentation Cardiovascular Interventions 2018

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

October 26, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

Presentation

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

April 23, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Daily News

Women Receive Less Aggressive CABG Compared With Men

Yael L. Maxwell

September 29, 2017

Presentation ESC 2017

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

Presenter: Martin J. Holzmann

August 28, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

Presentation CHIP Florida 2017

Multivessel Disease and Low EF Case

Presenter: Raja Hatem

January 21, 2017

Advertisement

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

PCI Vs CABG for Multivessel and Unprotected LM Disease

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Update on PCI for LMCA and Multivessel Disease

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Women Receive Less Aggressive CABG Compared With Men

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Multivessel Disease and Low EF Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content